Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...
A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
The MarketWatch News Department was not involved in the creation of this content. SUMMIT, N.J., Dec. 3, 2025 /PRNewswire/ -- Vascarta Inc., is pleased to share results from a new study led by ...
A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...
Accurately measuring electrical signals and calcium levels in the heart can lead to earlier treatment of potentially fatal conditions, such as heart attack or congestive heart failure. Calcium plays ...
Injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function, showing possible clinical relevance “It is widely acknowledged ...
After developing heart failure, 52.6 percent of patients die within five years, and the most significant cause of heart failure is a heart attack, which affects more than 800,000 Americans each year.
Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback